Innovative Medicines for Tuberculosis Foundation (iM4TB)
Lausanne, Switzerland
Purpose
to investigate the clinical safety, bioavailability and tolerability of a novel drug candidate for the treatment of tuberculosis (TB)
Division
Global Health
Date
March 2017
Region Served
GLOBAL
Committed amount
$2,798,456
Grant topic
Tuberculosis
Duration (months)
57
Grantee location
Lausanne, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.